|
|
Volumn 37, Issue 3 PART 2, 2008, Pages 444-459
|
|
Systemic lupus erythematosus: news and therapeutic perspectives;Actualités et perspectives thérapeutiques du lupus systémique
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABATACEPT;
ABETIMUS;
ALPHA1 INTERFERON;
AZATHIOPRINE;
B CELL ACTIVATING FACTOR;
BELIMUMAB;
CELECOXIB;
CYCLIN DEPENDENT KINASE;
CYCLOPHOSPHAMIDE;
ESTRADIOL;
ESTROGEN;
HYDROXYCHLOROQUINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMATINIB;
LEVONORGESTREL;
MEDROXYPROGESTERONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
PLACEBO;
RAPAMYCIN;
RITUXIMAB;
TACROLIMUS;
TAMOXIFEN;
TRANSFORMING GROWTH FACTOR BETA;
TUMOR NECROSIS FACTOR ALPHA;
IMMUNOLOGIC FACTOR;
ANTIPHOSPHOLIPID SYNDROME;
ATHEROMATOSIS;
CLINICAL TRIAL;
CONTRACEPTION;
CONTROLLED CLINICAL TRIAL;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE SEVERITY;
ENZYME INHIBITION;
HORMONE SUBSTITUTION;
HUMAN;
LUPUS ERYTHEMATOSUS NEPHRITIS;
MORBIDITY;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
SMOKING CESSATION;
SYSTEMIC LUPUS ERYTHEMATOSUS;
VACCINATION;
IMMUNOLOGY;
IMMUNOTHERAPY;
REVIEW;
HUMANS;
IMMUNOLOGIC FACTORS;
IMMUNOTHERAPY;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
|
|
EID: 41649100880
PISSN: 07554982
EISSN: None
Source Type: Journal
DOI: 10.1016/j.lpm.2007.11.011 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (130)
|
